Wells Fargo & Company Issues Pessimistic Forecast for Kezar Life Sciences (NASDAQ:KZR) Stock Price
Kezar Life Sciences (NASDAQ:KZR – Free Report) had its price target lowered by Wells Fargo & Company from $20.00 to $11.00 in a research note released on Thursday,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock. KZR has been the topic of a number of other reports. William Blair […]
More Stories
Heidelberg Materials (ETR:HEI) Shares Cross Above 200 Day Moving Average – Time to Sell?
Heidelberg Materials AG (ETR:HEI – Get Free Report) crossed above its two hundred day moving average during trading on Wednesday...
John Seaman Acquires 25,000 Shares of i-80 Gold Corp. (TSE:IAU) Stock
i-80 Gold Corp. (TSE:IAU – Get Free Report) Director John Seaman bought 25,000 shares of the company’s stock in a...
Short Interest in The Swatch Group AG (OTCMKTS:SWGNF) Increases By 36.1%
The Swatch Group AG (OTCMKTS:SWGNF – Get Free Report) was the recipient of a large increase in short interest in...
North Midland Construction (LON:NMD) Share Price Passes Below 200 Day Moving Average – What’s Next?
North Midland Construction PLC (LON:NMD – Get Free Report)’s stock price crossed below its 200-day moving average during trading on...
Portmeirion Group (LON:PMP) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?
Portmeirion Group PLC (LON:PMP – Get Free Report)’s share price crossed above its two hundred day moving average during trading...
Supermarket Income REIT plc (OTCMKTS:SUPIF) Short Interest Update
Supermarket Income REIT plc (OTCMKTS:SUPIF – Get Free Report) was the recipient of a significant growth in short interest in...